Holen Sie sich die Stockscreener-App
0.98
6.67%
-0.07
Skye Bioscience Inc Aktie (SKYE) Neueste Nachrichten
Published on: 2026-01-11 00:47:59 - ulpravda.ru
What margin trends mean for Skye Bioscience Inc. stockJuly 2025 Closing Moves & Stepwise Swing Trade Plans - ulpravda.ru
SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights - The AI Journal
SKYE FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action – SKYE - GlobeNewswire Inc.
Skye Bioscience, Inc. Class Action: Levi & Korsinsky Reminds Skye Bioscience, Inc. ... - Bluefield Daily Telegraph
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide - TipRanks
SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - FinancialContent
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your RightsSKYE - Sahm
Is Skye Bioscience Inc. (09R) stock a safe buy pre earnings2025 Winners & Losers & AI Powered Trade Plan Recommendations - ulpravda.ru
Is Skye Bioscience Inc. stock a safe haven assetQuarterly Portfolio Report & AI Powered Trade Plan Recommendations - ulpravda.ru
Securities Lawsuit Alert: Skye Bioscience, Inc. (SKYE)Contact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
Levi & Korsinsky Notifies Skye Bioscience, Inc. (SKYE) InvestorsLead Plaintiff Deadline on January 16, 2026 - ACCESS Newswire
Class Action Filed Against Skye Bioscience, Inc. (SKYE) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
Why hedge funds are buying Skye Bioscience Inc. stock2025 Investor Takeaways & AI Forecast Swing Trade Picks - ulpravda.ru
Bronstein, Gewirtz & Grossman LLC Urges Skye Bioscience, - GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pend - GuruFocus
Treasury Yields: Is Skye Bioscience Inc. (09R) stock worth holding before Fed meetingPortfolio Gains Summary & Daily Stock Trend Watchlist - ulpravda.ru
Lawsuit Alert: Investors who lost money with shares of Skye - openPR.com
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Your Wyoming Link
A Look At Halozyme Therapeutics (HALO) Valuation After New ENHANZE Obesity Partnership With Skye Bioscience - Yahoo Finance
Burned by Skye Bioscience, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Se - GuruFocus
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit - Your Wyoming Link
Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SKYE - GlobeNewswire
ROSEN, A TOP-RANKED LAW FIRM, Encourages Skye Bioscience, - GlobeNewswire
SKYE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
SKYE LAWSUIT ALERT: Levi & Korsinsky Notifies Skye Bioscience, Inc. InvestorsLead Plaintiff Deadline January 16, 2026 - ACCESS Newswire
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm - PR Newswire
Lost Money on Skye Bioscience, Inc. (SKYE)? Contact Levi & Korsinsky Before January 16, 2026 to Join Class Action - ACCESS Newswire
HALO, Skye Bioscience team up on obesity drug development - Longevity.Technology
Lost Money on Skye Bioscience, Inc. (SKYE)? Contact Levi & Korsinsky to Join Class Action Before January 16, 2026 - ACCESS Newswire
Skye Bioscience, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your RightsSKYE - Finviz
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire
Fibonacci Retracement Aligns with Support in Rudra Ecovation LimitedEx-Dividend Date Alerts & Free Long-Term Investment Planning - earlytimes.in
Skye Bioscience shares rise on Halozyme partnership to advance obesity treatment - MSN
Investors in Skye Bioscience, Inc. (SKYE): Protect Your RightsContact Levi & Korsinsky Before January 16, 2026 - ACCESS Newswire
Shareholders SueWallSt in New Class Action Against Skye Bioscience, Inc.Act Now - ACCESS Newswire
Shareholders of Skye Bioscience, Inc. (SKYE): Protect Your Rights Before January 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
Citizens reiterates Market Outperform rating on Skye Bioscience stock By Investing.com - Investing.com Canada
The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc - GuruFocus
Halozyme Therapeutics, Skye Bioscience Collaborate to Evaluate Nimacimab for Obesity Treatment - MarketScreener
Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology - Contract Pharma
The Gross Law Firm Notifies Shareholders of Skye Bioscience, Inc.(SKYE) of a Class Action Lawsuit and an Upcoming Deadline - Barchart.com
Skye Bioscience stock jumps after Halozyme collaboration for obesity drug By Investing.com - Investing.com Nigeria
Skye Bioscience stock jumps after Halozyme collaboration for obesity drug - Investing.com
Halozyme Therapeutics (HALO) Partners with Skye Bioscience for I - GuruFocus
Halozyme (HALO) Partners with Skye Bioscience for Obesity Treatm - GuruFocus
Skye Bioscience rises as it partners with Halozyme on obesity drug - TradingView — Track All Markets
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity - The Manila Times
SKYE ALERT: Securities Fraud Class Action Launched Against Skye Bioscience, Inc.January 16, 2026 Deadline - ACCESS Newswire
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):